Education
About Us
Working with TipRanks
Follow Us
Arterra Bioscience SpA (IT:ARBS)
:ARBS
Total Valuation
Arterra Bioscience SpA has a market cap or net worth of €15.58M. The enterprise value is €7.75M.
Market Cap€15.58M
Enterprise Value€7.75M
Share Statistics
Arterra Bioscience SpA has 6,658,493 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,658,493
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Arterra Bioscience SpA’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -10.74%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)-10.74%
Return on Capital Employed (ROCE)-0.13
Revenue Per Employee111.21K
Profits Per Employee35.87K
Employee Count30
Asset Turnover0.27
Inventory Turnover1.10
Valuation Ratios
The current PE Ratio of Arterra Bioscience SpA is 10.27. Arterra Bioscience SpA’s PEG ratio is 0.43.
PE Ratio10.27
PS Ratio0.00
PB Ratio1.37
Price to Fair Value1.03
Price to FCF11.09
Price to Operating Cash Flow10.31
PEG Ratio0.43
Income Statement
In the last 12 months, Arterra Bioscience SpA had revenue of 3.34M and earned 1.08M in profits. Earnings per share was 0.16.
Revenue3.34M
Gross Profit1.85M
Operating Income-1.53M
Pretax Income1.30M
Net Income1.08M
EBITDA1.84M
Earnings Per Share (EPS)0.16
Cash Flow
In the last 12 months, operating cash flow was 1.21M and capital expenditures -166.41K, giving a free cash flow of 526.06K billion.
Operating Cash Flow1.21M
Free Cash Flow526.06K
Free Cash Flow per Share0.08
Dividends & Yields
Arterra Bioscience SpA pays an annual dividend of €0.129, resulting in a dividend yield of 4.82%
Dividend Per Share€0.129
Dividend Yield4.82%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.34
52-Week Price Change24.47%
50-Day Moving Average2.25
200-Day Moving Average1.97
Relative Strength Index (RSI)56.92
Average Volume (3m)10.75K
Important Dates
Arterra Bioscience SpA upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend DateMay 05, 2025
Financial Position
Arterra Bioscience SpA as a current ratio of 9.35, with Debt / Equity ratio of 4.67%
Current Ratio9.35
Quick Ratio7.74
Debt to Market Cap0.03
Net Debt to EBITDA-1.79
Interest Coverage Ratio-152.98
Taxes
In the past 12 months, Arterra Bioscience SpA has paid 226.03K in taxes.
Income Tax226.03K
Effective Tax Rate0.17
Enterprise Valuation
Arterra Bioscience SpA EV to EBITDA ratio is 4.20, with an EV/FCF ratio of 8.22.
EV to Sales2.32
EV to EBITDA4.20
EV to Free Cash Flow8.22
EV to Operating Cash Flow7.56
Balance Sheet
Arterra Bioscience SpA has €3.43M in cash and marketable securities with €342.97K in debt, giving a net cash position of -€3.08M billion.
Cash & Marketable Securities€3.43M
Total Debt€342.97K
Net Cash-€3.08M
Net Cash Per Share-€0.46
Tangible Book Value Per Share€1.61
Margins
Gross margin is 13.83%, with operating margin of -45.97%, and net profit margin of 32.26%.
Gross Margin13.83%
Operating Margin-45.97%
Pretax Margin39.03%
Net Profit Margin32.26%
EBITDA Margin55.29%
EBIT Margin39.33%
Analyst Forecast
The average price target for Arterra Bioscience SpA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―